Kyushu University
Clinical trials sponsored by Kyushu University, explained in plain language.
-
New abdominal injection tested for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new drug called GAIA-102 for people with advanced stomach or pancreatic cancer that has spread to the lining of the abdomen, causing fluid buildup. The drug is injected directly into the abdomen, either alone or combined with an existing immunotherapy drug…
Phase: PHASE1, PHASE2 • Sponsor: Kyushu University • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for kids with tough cancers: experimental drug trial begins
Disease control Recruiting nowThis early-stage trial is testing a new drug called GAIA-102 in children and young adults (ages 1-24) whose cancers have come back or haven't responded to standard treatments. The main goal is to find a safe dose and see how well the body tolerates GAIA-102, both by itself and wh…
Phase: PHASE1 • Sponsor: Kyushu University • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC